MX9303973A - Piridinil-2-propenoatos sustituidos y sus homologos. - Google Patents

Piridinil-2-propenoatos sustituidos y sus homologos.

Info

Publication number
MX9303973A
MX9303973A MX9303973A MX9303973A MX9303973A MX 9303973 A MX9303973 A MX 9303973A MX 9303973 A MX9303973 A MX 9303973A MX 9303973 A MX9303973 A MX 9303973A MX 9303973 A MX9303973 A MX 9303973A
Authority
MX
Mexico
Prior art keywords
piridinil
approvals
pct
sec
substituted propenoates
Prior art date
Application number
MX9303973A
Other languages
English (en)
Inventor
Robert A Daines
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of MX9303973A publication Critical patent/MX9303973A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invención se refiere a un compuesto de la fórmula I: en donde los diversos grupos están definidos en la presente. Estos compuestos son antagonistas de leucotrieno y, como tales, pueden ser usados para tratar diversas enfermedades asociadas con los leucotrienos
MX9303973A 1992-06-30 1993-06-30 Piridinil-2-propenoatos sustituidos y sus homologos. MX9303973A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90677192A 1992-06-30 1992-06-30
US2519893A 1993-03-02 1993-03-02

Publications (1)

Publication Number Publication Date
MX9303973A true MX9303973A (es) 1994-04-29

Family

ID=26699422

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9303973A MX9303973A (es) 1992-06-30 1993-06-30 Piridinil-2-propenoatos sustituidos y sus homologos.

Country Status (16)

Country Link
US (1) US5990314A (es)
EP (1) EP0649412B1 (es)
JP (1) JP3230682B2 (es)
KR (1) KR950702185A (es)
CN (1) CN1108247A (es)
AT (1) ATE231129T1 (es)
AU (2) AU4545893A (es)
CA (1) CA2138954A1 (es)
DE (1) DE69332640T2 (es)
ES (1) ES2191014T3 (es)
IL (1) IL106156A0 (es)
MA (1) MA22926A1 (es)
MX (1) MX9303973A (es)
NZ (1) NZ253967A (es)
SI (1) SI9300349A (es)
WO (1) WO1994000437A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3775685B2 (ja) 1993-07-28 2006-05-17 ローン−プーラン・ロレ・リミテツド Pde▲iv▼およびtnf抑制剤としての化合物
AU1335795A (en) * 1993-12-08 1995-06-27 Smithkline Beecham Corporation Compounds
WO1995015752A1 (en) * 1993-12-09 1995-06-15 Smithkline Beecham Corporation Diphenyl-2-propenoates and homologs thereof useful for treating diseases associated with leukotriene b4
DE69609820T2 (de) * 1995-03-02 2001-03-08 Smithkline Beecham Corp., King Of Prussia Verwendung von substituirten Pyridinverbindungen zur Behandlung der atopischen Dermatitis und der Kontaktdermatitis
GB9508137D0 (en) * 1995-04-21 1995-06-07 Smithkline Beecham Plc Formulation
GB9602675D0 (en) * 1996-02-09 1996-04-10 Smithkline Beecham Plc Process
US5929096A (en) * 1996-02-29 1999-07-27 Smithkline Beecham Corporation Method for treating atopic dermatitis and contact dermatitis
EP0942903A1 (en) * 1996-09-26 1999-09-22 Novartis AG Aryl-substituted acrylamides with leukotriene b4 (ltb-4) receptor antagonist activity
US7361671B2 (en) * 2001-11-15 2008-04-22 The Institute For Pharmaceutical Discovery, Inc. Substituted heteroarylalkanoic acids

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT64748A (en) * 1990-06-07 1994-02-28 Smithkline Beecham Corp Method for producing benzoic acid derivatives and pharmaceutical preparatives containing said compounds
EP0593464A1 (en) * 1990-06-07 1994-04-27 Smithkline Beecham Corporation BENZOIC ACID DERIVATIVES and their use as LTB4 inhibitors
US5643914A (en) * 1993-03-02 1997-07-01 Smithkline Beecham Corporation Pharmaceutical pyridine compounds

Also Published As

Publication number Publication date
JP3230682B2 (ja) 2001-11-19
JPH07508284A (ja) 1995-09-14
DE69332640T2 (de) 2003-11-06
CA2138954A1 (en) 1994-01-06
MA22926A1 (fr) 1994-04-01
CN1108247A (zh) 1995-09-13
EP0649412A4 (en) 1995-07-05
EP0649412A1 (en) 1995-04-26
NZ253967A (en) 1996-11-26
KR950702185A (ko) 1995-06-19
ATE231129T1 (de) 2003-02-15
ES2191014T3 (es) 2003-09-01
WO1994000437A1 (en) 1994-01-06
AU707102B2 (en) 1999-07-01
DE69332640D1 (de) 2003-02-20
AU4545893A (en) 1994-01-24
AU2280797A (en) 1997-08-14
US5990314A (en) 1999-11-23
SI9300349A (sl) 1993-12-31
EP0649412B1 (en) 2003-01-15
IL106156A0 (en) 1993-10-20

Similar Documents

Publication Publication Date Title
NO970163D0 (no) Anvendelse av heterocycliske forbindelser
BR9106432A (pt) Indolona neuroprotetora e derivados correlatos
ES2092113T3 (es) Derivados fluoroalcoxibencilamino de heterociclos que contienen nitrogeno.
DE69225970D1 (de) Substituierte 2-phenyl-3-methocypropensäurenester als fungizide mittel.
DE59511017D1 (de) [a]-ANNELIERTE PYRROLDERIVATE UND DEREN ANWENDUNG IN DER PHARMAZIE
FI970147A0 (fi) Triatsoliyhdisteitä ja niiden käyttö dopamiini-D3-ligandeina
MX9303973A (es) Piridinil-2-propenoatos sustituidos y sus homologos.
DE69311541D1 (de) Kosmetische oder pharmazeutische zusammensetzungen zur topischen anwendung die deacylierten glycerophospholipide enthalten
FI973221A0 (fi) 1-aryyli-2-asyyliammo-etaaniyhdisteitä ja niiden käyttö neurokiniiniantagonisteina, erityisesti neurokiniini 1 antagonisteina
DE69808099D1 (de) Substituierte 6-alkylphenanthridine
KR950700913A (ko) 브릿지된 비스-아릴 카비놀 유도체, 조성물 및 사용방법(Bridged bis arylcarbinol derivatives, compositions and methods of use)
NO924361L (no) Formazan parasittiske midler
NO308829B1 (no) Anvendelse av forbindelsen finasterid for fremstilling av et preparat for behandling av kronisk prostatitt hos menn
FI922839A (fi) Foerfarande foer behandling av trombosytopeni och daervid anvaendbara farmaceutiska kompositioner.
ES2098119T3 (es) Nuevas triazoloquinazolinas, su obtencion y empleo.